Chen ZJ - Search Results

1

Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome.

Chen JY, He PC, Liu YH, Wei XB, Jiang L, Guo W, Duan CY, Guo YS, Yu XP, Li J, Li WS, Zhou YL, Lin CY, Luo JF, Yu DQ, Chen ZJ, Chen W, Chen YY, Guo ZQ, Geng QS, Tan N. Chen JY, et al. Among authors: chen zj, chen yy, chen w. JAMA Intern Med. 2019 Feb 1;179(2):186-194. doi: 10.1001/jamainternmed.2018.5953. JAMA Intern Med. 2019. PMID: 30592483 Free PMC article.

2

The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine.

Liu Y, Tan N, Chen J, Zhou Y, Chen L, Chen S, Chen Z, Li L. Liu Y, et al. Clinics (Sao Paulo). 2013 Jan;68(1):19-25. doi: 10.6061/clinics/2013(01)oa04. Clinics (Sao Paulo). 2013. PMID: 23420152 Free PMC article.

3

Use of the contrast volume or grams of iodine-to-creatinine clearance ratio to predict mortality after percutaneous coronary intervention.

Tan N, Liu Y, Chen JY, Zhou YL, Li X, Li LW, Yu DQ, Chen ZJ, Liu XQ, Huang SJ. Tan N, et al. Among authors: chen zj, chen jy. Am Heart J. 2013 Apr;165(4):600-8. doi: 10.1016/j.ahj.2012.12.017. Epub 2013 Feb 14. Am Heart J. 2013. PMID: 23537978

4

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.

Gao RL, Xu B, Lansky AJ, Yang YJ, Ma CS, Han YL, Chen SL, Li H, Zhang RY, Fu GS, Yuan ZY, Jiang H, Huo Y, Li W, Zhang YJ, Leon MB; TARGET I Investigators. Gao RL, et al. EuroIntervention. 2013 May 20;9(1):75-83. doi: 10.4244/EIJV9I1A12. EuroIntervention. 2013. PMID: 23685298 Free article. Clinical Trial.

5

Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.

Li ZG, Li G, Zhou YL, Chen ZJ, Yang JQ, Zhang Y, Sun S, Zhong SL. Li ZG, et al. Among authors: chen zj. Lipids Health Dis. 2013 Aug 27;12:127. doi: 10.1186/1476-511X-12-127. Lipids Health Dis. 2013. PMID: 23978127 Free PMC article. Clinical Trial.

6

Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovascular events in Han Chinese patients with coronary artery disease.

Li ZG, Wu H, Zhou YL, Chen ZJ, Meng JX, Yang JQ, Chen JY, Zhong SL. Li ZG, et al. Among authors: chen zj, chen jy. Chin Med J (Engl). 2013;126(24):4679-84. Chin Med J (Engl). 2013. PMID: 24342311

7

LDL cholesterol as a novel risk factor for contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.

Liu YH, Liu Y, Chen JY, Zhou YL, Chen ZJ, Yu DQ, Luo JF, Li HL, He YT, Ye P, Ran P, Guo W, Tan N. Liu YH, et al. Among authors: chen zj, chen jy. Atherosclerosis. 2014 Dec;237(2):453-9. doi: 10.1016/j.atherosclerosis.2014.10.022. Epub 2014 Oct 17. Atherosclerosis. 2014. PMID: 25463073

8

Arg⁹⁷² insulin receptor substrate-1 inhibits endothelial nitric oxide synthase expression in human endothelial cells by upregulating microRNA-155.

Huang C, Li G, Dong H, Sun S, Chen H, Luo D, Sun L, Li X, Chen Z, Yang H, Wei S, Zhou Y. Huang C, et al. Int J Mol Med. 2015 Jul;36(1):239-48. doi: 10.3892/ijmm.2015.2192. Epub 2015 Apr 21. Int J Mol Med. 2015. PMID: 25902041

9

Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy.

Liu Y, Chen JY, Tan N, Zhou YL, Yu DQ, Chen ZJ, He YT, Liu YH, Luo JF, Huang WH, Li G, He PC, Yang JQ, Xie NJ, Liu XQ, Yang DH, Huang SJ, Piao-Ye, Li HL, Ran P, Duan CY, Chen PY. Liu Y, et al. Among authors: chen zj, chen jy, chen py. Circ Cardiovasc Interv. 2015 Jun;8(6):e001859. doi: 10.1161/CIRCINTERVENTIONS.114.001859. Circ Cardiovasc Interv. 2015. PMID: 26041500

10

Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography.

Chen SQ, Liu Y, Smyth B, Li HL, Sun GL, Chen ZJ, Zhou YL. Chen SQ, et al. Among authors: chen zj. Heart Lung Circ. 2019 Jun;28(6):866-873. doi: 10.1016/j.hlc.2018.04.291. Epub 2018 May 16. Heart Lung Circ. 2019. PMID: 29960836 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,924 results

Search Page